Chemical injuries to the ocular surface can be challenging to manage because they lie at the intersection of urgency and long-term consequences. The severity of these injuries depends on the type of ...

Contact lenses are safe and effective, but wearing them during some activities can increase the risk of rare but serious ...

Samsung Bioepis Co., Ltd. today announced the relaunch of BYOOVIZ® (ranibizumab-nuna) in the United States (US), in ...

Hyperbaric oxygen therapy was well tolerated in treatment-refractory ulcerative colitis and enhanced clinical outcomes alongside improved bowel perfusion.

Samsung Bioepis Co., Ltd. announced the relaunch of Byooviz (ranibizumab-nuna) in the United States (US), in partnership with Harrow. Harrow became responsible for commercialization of Byooviz ...

Expands Harrow's Growing Retina Portfolio with an Interchangeable Ranibizumab BiosimilarNASHVILLE, Tenn., July 01, 2026 ...

Porcine corneal grafts offer a potential answer to donor cornea shortages, but researchers urge larger studies to confirm safety, tolerability, and long-term efficacy.

FRONT-2 global enrollment completed approximately 4 months ahead of initial projections4FRONT-2 over-enrolled (anticipated N>500), with final ...

Samsung Bioepis and Organon have expanded their development and commercialization agreement, whereby Organon will obtain ...

REGENXBIO Inc., a biotechnology company on a mission to improve lives through the curative potential of gene therapy, announced the first patient has been dosed in the phase IIb/III NAAVIGATE clinical ...

Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company, today announced the successful dosing of the first patient ...